Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Tim A. Kanters"'
Autor:
Cornelis L. P. van de Ree, Kari Ploegsma, Tim A. Kanters, Jan A. Roukema, Mariska A. C. De Jongh, Taco Gosens
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-11 (2018)
Abstract Background Reforms in the Dutch healthcare system in combination with the aging of the population will lead to a strong increase in the demand for informal care in the Netherlands. A hip fracture is one of the most important causes of hospit
Externí odkaz:
https://doaj.org/article/2adf2034356e421a8b63232fb8d57995
Autor:
Catharina M. Mulders-Manders, Tim A. Kanters, Paul L. A. van Daele, Esther Hoppenreijs, G. Elizabeth Legger, Jan A. M. van Laar, Anna Simon, Leona Hakkaart-van Roijen
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background Cryopyrin-associated periodic syndrome (CAPS) is a rare disease. Knowledge on the quality of life (QoL) and the disease’s societal impact is limited. Canakinumab is used in increasing frequency for the treatment of CAPS. Methods
Externí odkaz:
https://doaj.org/article/06ed263f127049a18feb160b88292e63
Autor:
Tim A. Kanters, Ans T. van der Ploeg, Michelle E. Kruijshaar, Dimitris Rizopoulos, W. Ken Redekop, Maureen P. M. H. Rutten-van Mӧlken, Leona Hakkaart-van Roijen
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-12 (2017)
Abstract Background Pompe disease is a rare, progressive, metabolic disease, and the first treatable inheritable muscle disorder. Enzyme replacement therapy (ERT) with alglucosidase alfa is disease specific and the only medicinal product authorized f
Externí odkaz:
https://doaj.org/article/9cfbaaa5b920451e8ecd10d255dadfc6
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Introduction: Introducing biosimilar infliximab for the treatment in rheumatology (rheumatoid arthritis and ankylosing spondylitis) and inflammatory bowel disease (Crohn's disease and ulcerative colitis) may reduce treatment costs associated with bio
Externí odkaz:
https://doaj.org/article/7a0250eba76b46c99fed8cde343a2bd2
Autor:
Katharina Abraham, Tim Andre Kanters, Adrian Stuart Wagg, Nicole Huige, Edward Hutt, Maiwenn Johanna Al
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/6719acfa83094da9a5e44c0c272d6e99
Publikováno v:
Journal of Allergy and Clinical Immunology: In Practice. Elsevier Inc.
Journal of Allergy and Clinical Immunology: In Practice
Journal of Allergy and Clinical Immunology: In Practice
Background: According to the current treatment guidelines, the goals of treatment of patients with hereditary angioedema (HAE) are to achieve total control of the disease and to normalize patients’ lives. Objective: This study aims to establish the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065916ce8ecc2f7129e8b0bbd86ae01b
https://doi.org/10.1016/j.jaip.2023.03.032
https://doi.org/10.1016/j.jaip.2023.03.032
Autor:
Werner B. F. Brouwer, Job van Exel, Leona Hakkaart-van Roijen, Ayesha Sajjad, Tim A. Kanters, Samare P. I. Huls
Publikováno v:
PharmacoEconomics, 40(1), 77-90. Adis
Pharmacoeconomics
Pharmacoeconomics
Background and Objective: The COVID-19 pandemic and the measures taken by governments to contain it have affected many aspects of the daily lives of citizens. This study aimed to describe changes in the productivity of paid work and time allocation t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b64e7d4b2b4bdc96458dbc973351108
https://doi.org/10.1007/s40273-021-01078-7
https://doi.org/10.1007/s40273-021-01078-7
Publikováno v:
Pharmacoeconomics
The emergence of gene therapies challenge health economists to evaluate interventions that are often provided to a small patient population with a specific gene mutation in a single dose with high upfront costs and uncertain long-term benefits. The o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd886dc1d63c899231013ac5a8dcc0f
https://doi.org/10.1007/s40273-021-01003-y
https://doi.org/10.1007/s40273-021-01003-y
Publikováno v:
Value in Health, 24(2), 236-243. Elsevier Ltd.
Objectives Patients with atrial fibrillation (AF) have rapid and irregular heart rates, increasing the risk of comorbidities and mortality. Next to formal medical care, many patients receive informal care from their social environment. The objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a22387e62996115db53b76dceac12ac
https://doi.org/10.1016/j.jval.2020.09.011
https://doi.org/10.1016/j.jval.2020.09.011
Cost Effectiveness of Splenic Artery Embolization versus Splenectomy after Trauma in the Netherlands
Autor:
Tim A. Kanters, Claudia P.A.M. Raaijmakers, Paul N.M. Lohle, Jolanda de Vries, Leona Hakkaart-van Roijen, C.P.A.M. Raaijmakers, P.N.M. Lohle, J. de Vries, F.H.W.M. van der Heijden, C.H.J. Schonenberg, M.H.J. Verhofstad, A. Moelker, H.P. de Graaff, D. Vroegindeweij, C.H. van der Vlies, K.C. Smit, O.E.H. Elgersma, T.S.C. Jakma, H.S. Roodenburg, L.D. Vos, P.J.H.J. Romme, S.M. Zielinski, A.R. Alberts, J. van der Slegt, C.S.P. van Rijswijk, K.A. Bartlema, G. Labadie, M.R. Meijerink, W.P. Zuidema, C. van Dam, C.A.H. Klazen, R.J. de Wit, A. Goolkate, M.J.R. Edwards, H.M. Dekker, T. Tromp, B.A.A.M. van Hasselt, S.H. van Helden, L. Buitenhuis
Publikováno v:
Journal of Vascular and Interventional Radiology, 33(4), 392-398.e4. Elsevier Inc.
Journal of Vascular and Interventional Radiology, 33, 4, pp. 392-398 e4
Journal of Vascular and Interventional Radiology, 33, 392-398 e4
SPLENIQ study group 2022, ' Cost Effectiveness of Splenic Artery Embolization versus Splenectomy after Trauma in the Netherlands ', Journal of Vascular and Interventional Radiology, vol. 33, no. 4, pp. 392-398.e4 . https://doi.org/10.1016/j.jvir.2021.12.011
Journal of Vascular and Interventional Radiology, 33, 4, pp. 392-398 e4
Journal of Vascular and Interventional Radiology, 33, 392-398 e4
SPLENIQ study group 2022, ' Cost Effectiveness of Splenic Artery Embolization versus Splenectomy after Trauma in the Netherlands ', Journal of Vascular and Interventional Radiology, vol. 33, no. 4, pp. 392-398.e4 . https://doi.org/10.1016/j.jvir.2021.12.011
Contains fulltext : 252067.pdf (Publisher’s version ) (Closed access) PURPOSE: To demonstrate that splenic artery embolization (SAE) is more cost-effective than splenectomy from a societal perspective in the Netherlands. MATERIALS AND METHODS: Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415df66e67a2aed20a14f57f460d8dee
https://pure.eur.nl/en/publications/f11e6c72-2a57-40fc-9001-42c6ed2b12af
https://pure.eur.nl/en/publications/f11e6c72-2a57-40fc-9001-42c6ed2b12af
